20 Jun 2018 16:26
20 June 2018
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected Persons
On 19 June 2018, pursuant to the rules of the Consort Medical plc Deferred Bonus Plan and the Consort Medical plc Performance Share Plan, the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares in the Company ("Ordinary Shares") at a share price of £12.33 each as detailed below:
Deferred Bonus Share Award (in respect of the financial year 2017/18)
Director/PDMR | Number of Ordinary Shares awarded |
Jonathan Glenn | 16,004 |
Paul Hayes | 8,629 |
Keyvan Djamarani | 4,709 |
Manja Boerman | 4,610 |
Performance Share Plan Award
Director/PDMR | Number of Ordinary Shares awarded |
Jonathan Glenn | 40,255 |
Paul Hayes | 25,952 |
Keyvan Djamarani | 14,963 |
Manja Boerman | 14,598 |
Each award was granted as a nil cost option.
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Jonathan Glenn
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) and Consort Medical Performance Share Plan (PSP)
| |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 16,004 (DBP) 40,255 (PSP) | ||||
d)
| Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Keyvan Djamarani | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Bespak Division | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan and Consort Medical Performance Share Plan (PSP)
| |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 4,709 (DBP) 14,963 (PSP) | ||||
d)
| Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Manja Boerman | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Manging Director Aesica Division | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) and the Consort Medical Performance Share Plan (PSP) | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 4,610 (DBP) 14,598 (PSP) | ||||
d)
| Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Paul Hayes | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CFO | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan (DBP) and the Consort Medical Performance Share Plan (PSP) | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 8,629 (DBP) 25,952 (PSP) | ||||
d)
| Aggregated information | n/a | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||